EP0235528A1 - Procédé de préparation d'huiles ozonisées stables à partir d'huiles végétales insaturées - Google Patents

Procédé de préparation d'huiles ozonisées stables à partir d'huiles végétales insaturées Download PDF

Info

Publication number
EP0235528A1
EP0235528A1 EP87100725A EP87100725A EP0235528A1 EP 0235528 A1 EP0235528 A1 EP 0235528A1 EP 87100725 A EP87100725 A EP 87100725A EP 87100725 A EP87100725 A EP 87100725A EP 0235528 A1 EP0235528 A1 EP 0235528A1
Authority
EP
European Patent Office
Prior art keywords
oil
oils
unsaturated vegetable
ascorbic acid
vegetable oils
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP87100725A
Other languages
German (de)
English (en)
Other versions
EP0235528B1 (fr
Inventor
Josef Prof. Dr. Dr. Dipl.-Ing. Washüttl
Renate Dr. Rer. Nat. Dipl.-Chem. Viebahn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hansler Dr J GmbH
Original Assignee
Hansler Dr J GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hansler Dr J GmbH filed Critical Hansler Dr J GmbH
Priority to AT87100725T priority Critical patent/ATE42965T1/de
Publication of EP0235528A1 publication Critical patent/EP0235528A1/fr
Application granted granted Critical
Publication of EP0235528B1 publication Critical patent/EP0235528B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11CFATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/006Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by oxidation

Definitions

  • the invention relates to a process for the production of stable ozonized oils from unsaturated vegetable oils with removal of physiologically questionable low molecular weight aldehydes and ketones.
  • the process according to the invention provides valuable products which are suitable for therapeutic and cosmetic use in humans and animals.
  • reaction of ozone with unsaturated fatty acids produces peroxidic products as therapeutically valuable active substances and low-molecular aldehydes and ketones, especially malondialdehyde, as undesirable by-products.
  • the peroxidic products are used, for example, in dermatology for fungal diseases, leg ulcers, poorly healing wounds, infected wounds and the like.
  • the ketones and aldehydes formed as by-products are therapeutically ineffective and largely physiologically questionable. The latter is particularly true for malondialdehyde, which occurs in considerable quantities when ozonization of unsaturated vegetable oils is complete (see Registry of Toxic Effects of Chemical Substances, U.S. Department of Health and Human Services, 1984).
  • the object of the invention is to provide ozonized products from unsaturated vegetable oils which are therapeutically valuable products, are stable for a long time and have the lowest possible content of low molecular weight aldehydes and ketones, in particular malondialdehyde.
  • the invention relates to a process for producing stable ozonized oils from unsaturated vegetable oils by introducing an ozone-oxygen mixture into the oil until saturation, which is characterized in that after the ozonization, an extraction treatment in an acidic environment in the presence of a redox system, preferably a biological redox system which is capable of a moderate radical reaction and which carries out in the presence of an artificial or natural antioxidant or reducing agent.
  • a redox system preferably a biological redox system which is capable of a moderate radical reaction and which carries out in the presence of an artificial or natural antioxidant or reducing agent.
  • unsaturated vegetable oils are olive oil, safflower oil, wheat germ oil, linseed oil, almond oil, nut oil, sunflower oil, poppy seed oil, sesame oil, castor oil, croton oil, soybean oil and palm oil. Olive and safflower oils are preferred. Olive oil is especially preferred.
  • the redox system used which is capable of radical reactions, acts in the organism both as an electron acceptor and as an electron donor.
  • Preferred examples of redox systems are ascorbic acid, the essentially membrane-associated redox system vitamin E, vitamin A and the biological quinoid / benzoid systems. Ascorbic acid is particularly preferred.
  • a pH of 3.5 to 6.5 has proven to be particularly suitable for carrying out the extraction treatment.
  • ascorbic acid or citric acid can be used.
  • antioxidants or reducing agents are butylated hydroxyanisole, gallate and hydrogen sulfite.
  • the ozone-oxygen mixture is produced in compliance with the regulations for the production or filling of medical oxygen.
  • the ozone is generated by a silent electrical discharge (absolutely nitrogen-free to avoid the formation of aggressive and reactive nitrogen oxides, especially radicals).
  • the ozonization of the oil is carried out with a continuous pass with a gas flow in the range of 1 to 2 liters per minute.
  • the ozone concentration used is preferably in the range from 50 to 70 ⁇ g per ml.
  • the oil is bubbled through using a cylindrical vessel with the highest possible “water column” with thermostatting at about 20 ° C.
  • a continuous flow is important, especially just before the saturation limit, which becomes apparent when the product solidifies at 20 ° C.
  • For 12 liters with a total height of the cylindrical vessel of 60 cm and a diameter of approx. 20 cm, a uniform bubbling time of 180 to 300 hours is required, depending on the ozone concentration of the initial ozone-oxygen mixture.
  • aqueous extraction solution For the extraction treatment, about 2 to 20, in particular 3 to 10 and preferably about 5 ml of aqueous extraction solution are used per 1 g of ozonized oil.
  • the extraction is preferably carried out by shaking for 10 to 60 minutes. The shaking process can be carried out several times to increase the effectiveness. Any excess sulfite still present in the extract can be removed by shaking out the oily phase with 2% aqueous ascorbic acid solution.
  • Particularly preferred combinations for the extraction treatment according to the invention are ascorbic acid + butylated hydroxyanisole, citric acid and butylated hydroxyanisole as well as ascorbic acid and hydrogen sulfite.
  • the determination is based on the reaction of malondialdehyde with 2-methylindole in alcoholic-hydrochloric acid solution to form a stable, intensely colored complex.
  • Determination of malondialdehyde in ozonized oil About 1 g of the solid oil is weighed exactly and warmed to liquefy under an N2 atmosphere (approx. 30 ° C). Since the oil is immiscible with the reagents, 1 ml of distilled H2O are added in addition to 2 ml of methyl indole and stirred with a magnetic stirrer under the N2 atmosphere during the 20 min reaction time to allow a complete reaction of the malondialdehyde. The alcoholic phase is then measured (after the fat has been removed) in comparison with the calibration series that is applied in parallel each time.
  • the product obtained has a peroxide number (POZ) of 929 and a malondialdehyde content of 445 ⁇ g / g of oil.
  • the extraction treatment removed 85 percent of the malondialdehyde, while the peroxide number only decreased by 5.7 percent.
  • the aqueous extract contains no peroxides, while the malondialdehyde has almost completely passed into the aqueous phase.
  • Samples of the ozonated olive oil produced according to Example 1 are subjected to different extraction treatments. For this purpose, 1 g ozonized oil is shaken out with various aqueous solutions for 15 minutes. The POZ and malondialdehyde content are then determined. The results are summarized in the table below.
  • x) 1 means that the parameter in question has not been determined
  • x) 2 excess sulfite was completely removed by shaking the oil with 10 ml H2O (2 g ascorbic acid / 100 ml), whereby the POZ and malondialdehyde content of the ozonated oil did not change significantly: the peroxide number decreased from 876 to 860, the malondialdehyde content from 68 ⁇ g / g to 52 ⁇ g / g.

Landscapes

  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
EP87100725A 1986-03-01 1987-01-20 Procédé de préparation d'huiles ozonisées stables à partir d'huiles végétales insaturées Expired EP0235528B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT87100725T ATE42965T1 (de) 1986-03-01 1987-01-20 Verfahren zur herstellung von stabilen ozonisierten oelen aus ungesaettigten pflanzenoelen.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3606735A DE3606735C2 (de) 1986-03-01 1986-03-01 Verfahren zur Herstellung von stabilen ozonisierten Ölen aus ungesättigten Pflanzenölen
DE3606735 1986-03-01

Publications (2)

Publication Number Publication Date
EP0235528A1 true EP0235528A1 (fr) 1987-09-09
EP0235528B1 EP0235528B1 (fr) 1989-05-10

Family

ID=6295281

Family Applications (1)

Application Number Title Priority Date Filing Date
EP87100725A Expired EP0235528B1 (fr) 1986-03-01 1987-01-20 Procédé de préparation d'huiles ozonisées stables à partir d'huiles végétales insaturées

Country Status (3)

Country Link
EP (1) EP0235528B1 (fr)
AT (1) ATE42965T1 (fr)
DE (1) DE3606735C2 (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025409A1 (fr) * 1995-02-16 1996-08-22 Cosmart Ag Compositions cosmetiques ou pharmaceutiques contenant une huile vegetale naturelle enrichie en ozonides et utilisations
FR2784388A1 (fr) * 1998-10-07 2000-04-14 Bernard Sonnois Huile ozonisee obtenue par generateur alimente en oxygene pur - huile saturee en ozone
WO2000078699A1 (fr) * 1999-06-18 2000-12-28 E.I. Du Pont De Nemours Clivage oxydant d'huiles insaturees et produits obtenues a partir de celles-ci
WO2001037829A1 (fr) * 1999-11-25 2001-05-31 Gomez Moraleda Manuel Antonio Composition comprenant des huiles ozonisees et/ou autres produits naturels et/ou de synthese ozonises, et son utilisation dans des compositions pharmaceutiques, cosmetiques, dietetiques ou de complements alimentaires utilisees en medecine humaine et veterinaire
WO2006021924A1 (fr) * 2004-08-26 2006-03-02 Pieter Josua Le Roux Huile therapeutique
EP1681338A1 (fr) * 2003-10-02 2006-07-19 Sun Care Fuels Corporation Modificateur pour carburant biodiesel, carburant et procedes associes
WO2007046122A2 (fr) * 2005-10-17 2007-04-26 Bioo3Pharma S.R.L. Huile ozonisee, procede d'elaboration et utilisation dans le domaine medical
WO2010039064A1 (fr) * 2008-10-03 2010-04-08 Sca Hygiene Products Ab Lingette comprenant une substance désodorisante
RU2462271C1 (ru) * 2008-10-03 2012-09-27 Ска Хайджин Продактс Аб Влажная салфетка с дезодорирующим веществом
ITUB20155250A1 (it) * 2015-11-24 2017-05-24 Apuzzo Dario Nuova composizione nutraceutica, somministrabile per via orale, utile per esercitare una potente stimolazione del metabolismo, in particolare del metabolismo energetico muscolare.
IT202000024967A1 (it) * 2020-10-23 2022-04-23 Giovanni Sandomenico Fluido ozonizzato a presidio - difesa delle prime vie respiratorie

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10157260B4 (de) * 2001-11-22 2005-12-15 Pharmoxid Arznei Gmbh + Co. Kg Streichfähige Salbe mit Ozoniden und Peroxiden von Fettsäuren oder deren Estern
DE102012007239A1 (de) 2012-04-10 2013-10-10 Wolfgang Winkelmann Pharmazeutische Zusammensetzung enthaltend eine mit Sauerstoff angereicherte ungesättigte Fettsäure und ein organisches Lösungsmittel
DE102015001289A1 (de) 2015-01-29 2016-08-04 Wolfgang Winkelmann Pharmazeutische Zusammensetzungen und Pflanzenschutzmittel enthaltend mit Sauerstoff angereicherte Pflanzenöle oder Fettsäuren

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2083572A (en) * 1928-04-25 1937-06-15 Susan M Mckee Process of treating oil
DE1068251B (de) * 1959-11-05 Chemische Fabrik Stockhausen S. Oie, Krefeld Verfahren zur Herstellung von in Wasser löslichen bzw. emiuligierbaren, elektrolytbeständigen Fettungsmijtteln

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5869207A (ja) * 1981-10-21 1983-04-25 Nippon Petrochem Co Ltd エポキシ化物の精製方法
DE3373675D1 (en) * 1983-01-06 1987-10-22 Lepeltier Marie Francoise Process for the preparation of peroxydated fats by biological low energy transformation, products obtained by this process, mixtures of these products with additives and new medicines made up of these products

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1068251B (de) * 1959-11-05 Chemische Fabrik Stockhausen S. Oie, Krefeld Verfahren zur Herstellung von in Wasser löslichen bzw. emiuligierbaren, elektrolytbeständigen Fettungsmijtteln
US2083572A (en) * 1928-04-25 1937-06-15 Susan M Mckee Process of treating oil

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025409A1 (fr) * 1995-02-16 1996-08-22 Cosmart Ag Compositions cosmetiques ou pharmaceutiques contenant une huile vegetale naturelle enrichie en ozonides et utilisations
FR2730636A1 (fr) * 1995-02-16 1996-08-23 Cosmart Ag Huile vegetale naturelle enrichie en ozonides, compositions cosmetiques ou pharmaceutiques la contenant et utilisations
FR2784388A1 (fr) * 1998-10-07 2000-04-14 Bernard Sonnois Huile ozonisee obtenue par generateur alimente en oxygene pur - huile saturee en ozone
WO2000078699A1 (fr) * 1999-06-18 2000-12-28 E.I. Du Pont De Nemours Clivage oxydant d'huiles insaturees et produits obtenues a partir de celles-ci
US6768029B1 (en) 1999-06-18 2004-07-27 Cambridge Biopolymers Limited Oxidative cleavage of unsaturated oils and products obtained therefrom
WO2001037829A1 (fr) * 1999-11-25 2001-05-31 Gomez Moraleda Manuel Antonio Composition comprenant des huiles ozonisees et/ou autres produits naturels et/ou de synthese ozonises, et son utilisation dans des compositions pharmaceutiques, cosmetiques, dietetiques ou de complements alimentaires utilisees en medecine humaine et veterinaire
ES2162586A1 (es) * 1999-11-25 2001-12-16 Moraleda Manuel Gomez Composicion que comprende aceites ozonizados y/o otros productos naturales y/o sinteticos ozonizados, y su empleo en composiciones farmaceuticas, cosmeticas, dieteticas o de suplementos alimentarios, en los campos humano y veterinario
EP1681338A1 (fr) * 2003-10-02 2006-07-19 Sun Care Fuels Corporation Modificateur pour carburant biodiesel, carburant et procedes associes
EP1681338A4 (fr) * 2003-10-02 2008-11-19 Sun Care Fuels Corp Modificateur pour carburant biodiesel, carburant et procedes associes
WO2006021924A1 (fr) * 2004-08-26 2006-03-02 Pieter Josua Le Roux Huile therapeutique
WO2007046122A2 (fr) * 2005-10-17 2007-04-26 Bioo3Pharma S.R.L. Huile ozonisee, procede d'elaboration et utilisation dans le domaine medical
WO2007046122A3 (fr) * 2005-10-17 2007-06-14 Biopharma 3M S R L Huile ozonisee, procede d'elaboration et utilisation dans le domaine medical
WO2010039064A1 (fr) * 2008-10-03 2010-04-08 Sca Hygiene Products Ab Lingette comprenant une substance désodorisante
RU2462271C1 (ru) * 2008-10-03 2012-09-27 Ска Хайджин Продактс Аб Влажная салфетка с дезодорирующим веществом
ITUB20155250A1 (it) * 2015-11-24 2017-05-24 Apuzzo Dario Nuova composizione nutraceutica, somministrabile per via orale, utile per esercitare una potente stimolazione del metabolismo, in particolare del metabolismo energetico muscolare.
IT202000024967A1 (it) * 2020-10-23 2022-04-23 Giovanni Sandomenico Fluido ozonizzato a presidio - difesa delle prime vie respiratorie

Also Published As

Publication number Publication date
ATE42965T1 (de) 1989-05-15
DE3606735C2 (de) 1994-11-10
EP0235528B1 (fr) 1989-05-10
DE3606735A1 (de) 1987-09-10

Similar Documents

Publication Publication Date Title
EP0235528B1 (fr) Procédé de préparation d'huiles ozonisées stables à partir d'huiles végétales insaturées
DE3874428T2 (de) Maulbeerbaumextrakte enthaltende liposomzusammensetzung.
EP0060553B1 (fr) Médicament pour le traitement des blessures de la surface dermique et procédé de préparation dudit médicament
DE69807070T2 (de) Tocoferol estern und deren verwendung in kosmetika und pharmazie
DE4210112A1 (de) Polyethoxyliertes vitamin e und verfahren zu dessen herstellung
DE1917393A1 (de) Parfuemierte und aromatisierte Produkte
DE2102172C3 (de) Neue Mittel zur Behandlung und Pflege der Haut
DE3633453A1 (de) Zusammensetzungen auf der basis von lysin- und argininsalzen
DE2700448C2 (de) Salbe zur Behandlung von Ulcus Cruris
DE2129654B2 (de) Medikament zur Verminderung der Kapillarpermeabilität und Erhöhung der Kapillarstabilität aus der Extraktion der Flavanole enthaltenden Früchte von Vitis vinifera
AT414082B (de) Verfahren zur herstellung von tocotrienol-angereicherten präparationen
EP0339382B1 (fr) Procédé pour désodoriser des mélanges d'esters d'acides gras
DE69711633T2 (de) Stabile derivate von ubiquinol, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung
DE19728609C2 (de) Triglycerid-Sorbinsäure-Pantothenyl-Acetalperoxide aus natürlichen Pflanzenölen
DE3643323C2 (fr)
EP0005121B1 (fr) Procédé de stabilisation de 4-methyl-5-(2'chlorethyl)-thiazol
DE1568320B2 (de) Kosmetischer Wirkstoff und kosmetisches MIttel mit wasserretinierenden Eigenschaften
DE580515C (de) Verfahren zur Herstellung von Triarylstibinjodiden und deren Loesungen
EP0951904B1 (fr) Médicament et pour augmenter la microcirculation cutanéene
DE2855860C2 (de) Verfahren zur Reinigung Wasser enthaltender organischer Peroxide
DE2531260A1 (de) Verspruehbare, wasserfreie d-panthenolloesungen
DE60122696T2 (de) Methoden und zusammensetzung zur verbesserten sauerstoffzufuhr für zellen
DE2714342C2 (de) Bis(acetylsalicylsäure)-thiaalkandiol-ester und therapeutische Zusammensetzung
DE850054C (de) Toiletten- oder Rasierseife
DE624231C (de) Verfahren zur Herstellung von hydriertem Tachysterin

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH FR IT LI NL

17P Request for examination filed

Effective date: 19871015

17Q First examination report despatched

Effective date: 19880713

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH FR IT LI NL

REF Corresponds to:

Ref document number: 42965

Country of ref document: AT

Kind code of ref document: T

ET Fr: translation filed
ITF It: translation for a ep patent filed

Owner name: DR. ING. A. RACHELI & C.

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
ITTA It: last paid annual fee
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20031217

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20040116

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20040129

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20040130

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20040413

Year of fee payment: 18

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050120

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050120

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050131

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050131

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050131

BERE Be: lapsed

Owner name: *J. HANSLER G.M.B.H.

Effective date: 20050131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050801

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050930

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20050801

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

BERE Be: lapsed

Owner name: *J. HANSLER G.M.B.H.

Effective date: 20050131